December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
One-Year Results of a Multi-Center, United States Clinical Trial on Conductive Keratoplasty (CK) for Correcting Hyperopia
Author Affiliations & Notes
  • PA Asbell
    Department of Ophthalmology Mount Sinai Medical Center New York NY
  • Footnotes
    Commercial Relationships    P.A. Asbell, Refractec, Inc. F.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4126. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      PA Asbell; One-Year Results of a Multi-Center, United States Clinical Trial on Conductive Keratoplasty (CK) for Correcting Hyperopia . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4126.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Determine the 12-month efficacy and stability results of an FDA Phase III study of CK used to eyes for low to moderate hyperopia. Methods: Conductive keratoplasty is a technique that delivers radio frequency current directly into the corneal stroma. A Keratoplast Tip is inserted into the peripheral cornea at 8 to 32 treatment points to shrink collagen and produce a "cinching" effect that increases the curvature of the central cornea, thereby decreasing hyperopia. A total of 233 patients (390 eyes) with a mean preoperative MRSE of +1.82 ± 0.60 D and a peripheral pachymetry reading at the 6 mm optical zone no less than 560 microns were enrolled into the study at 13 US centers, underwent CK treatment, and were followed for one year. Total follow-up will be two years. Results: At one-year (N=171), 51% had postoperative UCVA 2020 or better, 73% had 20/25 or better, and 91% had 20/40 or better. The MRSE was within ±0.50 D in 58% and ±1.00 D in 91%. The refraction appeared to stabilize at six months, with a mean change in MRSE refraction of 0.26 D between three and six months, 0.09 D between six and nine months and 0.13 D between nine and 12 months. Conclusion: One-year data show excellent efficacy and stability of conductive keratoplasty in the treatment of hyperopia. The refractive effect appeared to stabilize at approximately six months.

Keywords: 427 hyperopia • 549 refractive surgery: other technologies • 357 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.